Bioactive Investor Presentation

Managing Director, Rick Ferdinands, reveals a New Pharmaceutical Disruption Model. This new model allows early revenue streams from ‘low risk’ listed plant based medicines, whilst drug discovery is advancing through collaborations.

Disruptive strategies such as these open the door to SMSF and sophisticated wholesale investors looking for early returns.

This presentation was delivered at the Wholesale Investor, Sydney event in June 2016.